Because of the uncertainty in the appropriate initial loop diuretic dose in acute decompensated heart failure (ADHF), the risk of acute kidney injury (AKI) is believed to be increased with the high dose of initial intravenous (IV) loop diuretic.
The purpose of this study is to examine the impact of the first 24-h IV diuretic on kidney function in ADHF.
A retrospective cohort study included patients with ADHF. These patients were divided into two groups: the first group received an initial total IV diuretic dose that was equal to or 2.5 times less than the home dose in the first 24 h (low dose), while the second group received 2.5 times more than the home dose in the first 24 h (high dose). The primary outcome was the incidence of developing AKI within 48 h of first IV diuretic. The secondary outcomes were total hospital length of stay and all-cause 30-day readmission rates.
A total of 252 patients were available for analysis; 172 patients received a low dose in the first 24 h, while 80 patients received a high dose. The incidence of AKI was higher in the high-dose group compared to that in the low-dose group (25% vs. 9.9%, P = 0.002). There was no significant difference between the two groups in terms of hospital stay and all-cause 30-day readmission.
In patients with ADHF, the initial high dose of IV loop diuretics is associated with an increased risk of developing AKI.
This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Tax calculation will be finalised during checkout.
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
Tax calculation will be finalised during checkout.
Nieminen MS, Harjola VP (2005) Definition and epidemiology of acute heart failure syndromes. Am J Cardiol 96(6A):5G–10G
National Clinical Guideline Centre (UK) (2010) Chronic heart failure: national clinical guideline for diagnosis and management in primary and secondary care. Royal College of Physicians (UK), London
McMurray JJ, Pfeffer MA (2005) Heart failure. Lancet 365(9474):1877–1889
Dassanayaka S, Jones SP (2015) Recent developments in heart failure. Circ Res 117(7):e58–e63
Metra M, Teerlink JR (2017) Heart failure. Lancet 390(10106):1981–1995
Roger VL (2013) Epidemiology of heart failure. Circ Res 113(6):646–659
Dickstein K, Cohen-Solal A, Filippatos G, McMurray J, Ponikowski P, Poole-Wilson PA et al (2008) ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J 29(19):2388–2442
Gheorghiade M, Zannad F, Sopko G, Klein L, Piña IL, Konstam MA, Massie BM, Roland E, Targum S, Collins SP, Filippatos G, Tavazzi L, International Working Group on Acute Heart Failure Syndromes (2005) Acute heart failure syndromes: current state and framework for future research. Circulation 112(25):3958–3968
Fang J, Mensah GA, Croft JB (2008) Keenan NL. Heart failure-related hospitalization in the U.S., 1979 to 2004. J Am Coll Cardiol 52(6):428–434
Peacock WF 4th, Fonarow GC, Emerman CL, Mills RM, Wynne J, ADHERE Scientific Advisory Committee and Investigators; Adhere Study Group (2007) Impact of early initiation of intravenous therapy for acute decompensated heart failure on outcomes in ADHERE. Cardiology 107(1):44–51. https://doi.org/10.1159/000093612
Maisel AS, Peacock WF, McMullin N, Jessie R, Fonarow GC, Wynne J, Mills RM (2008) Timing of immunoreactive B-type natriuretic peptide levels and treatment delay in acute decompensated heart failure: an ADHERE (Acute Decompensated Heart Failure National Registry) analysis. J Am Coll Cardiol 52(7):534–540
Howard PA, Dunn MI (2001) Aggressive diuresis for severe heart failure in the elderly. Chest 119(3):807–810
Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE Jr, Drazner MH, Fonarow GC, Geraci SA, Horwich T, Januzzi JL, Johnson MR, Kasper EK, Levy WC, Masoudi FA, McBride PE, McMurray JJV, Mitchell JE, Peterson PN, Riegel B, Sam F, Stevenson LW, Tang WHW, Tsai EJ, Wilkoff BL (2013) 2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation 128(16):1810–1852
Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS, Falk V, González-Juanatey JR, Harjola VP, Jankowska EA, Jessup M, Linde C, Nihoyannopoulos P, Parissis JT, Pieske B, Riley JP, Rosano GMC, Ruilope LM, Ruschitzka F, Rutten FH, van der Meer P, ESC Scientific Document Group (2016) 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J 37(27):2129–2200
Felker GM, Lee KL, Bull DA, Redfield MM, Stevenson LW, Goldsmith SR, LeWinter M, Deswal A, Rouleau JL, Ofili EO, Anstrom KJ, Hernandez AF, McNulty S, Velazquez EJ, Kfoury AG, Chen HH, Givertz MM, Semigran MJ, Bart BA, Mascette AM, Braunwald E, O’Connor CM, NHLBI Heart Failure Clinical Research Network (2011) Diuretics strategies in patients with acute decompensated heart failure. N Engl J Med 364(9):797–805
Dikshit K, Vyden JK, Forrester JS, Chatterjee K, Prakash R, Swan HJ (1973) Renal and extrarenal hemodynamic effects of furosemide in congestive heart failure after acute myocardial infarction. N Engl J Med 288(21):1087–1090
Butler J, Forman DE, Abraham WT, Gottlieb SS, Loh E, Massie BM, O’Connor CM, Rich MW, Stevenson LW, Wang Y, Young JB, Krumholz HM (2004) Relationship between heart failure treatment and development of worsening renal function among hospitalized patients. Am Heart J 147:331–338
Cooper HA, Dries DL, Davis CE, Shen YL, Domanski MJ (1999) Diuretics and risk of arrhythmic death in patients with left ventricular dysfunction. Circulation 100:1311–1315
Hasselblad V, Gattis Stough W, Shah MR, Lokhnygina Y, O’Connor CM, Califf RM et al (2007) Relation between dose of loop diuretics and outcomes in a heart failure population: results of the ESCAPE trial. Eur J Heart Fail 9:1064–1069
Felker GM, Leimberger JD, Califf RM, Cuffe MS, Massie BM, Adams KF Jr, Gheorghiade M, O’Connor CM (2004) Risk stratification after hospitalization for decompensated heart failure. J Card Fail 10:460–466
Fonarow GC, Adams KF Jr, Abraham WT, Yancy CW, Boscardin WJ, ADHERE Scientific Advisory Committee, Study Group, and Investigators (2005) Risk stratification for inhospital mortality in acutely decompensated heart failure: classification and regression tree analysis. JAMA 293:572–580
Alshibani M, Alshehri S, Alyazidi W, Alnomani A, Almatruk Z, Almeleebia T (2020) The impact of discharged loop diuretic dose to home dose on hospital readmissions in patients with acute decompensated heart failure: a retrospective cohort study. Heart Surg Forum 23(4):E470–E474
Conflict of interest
The authors declare that they have no conflict of interest.
This study was approved by the Unit of Biomedical Ethics Research Committee at King Abdulaziz University. All procedures performed in the current study were in accordance with the ethical standards of the institutional and national research committee.
All authors take responsibility for all aspects of the reliability and freedom from bias of the data presented and their discussed interpretation.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Alshibani, M., Alshehri, S., Bakhaider, A. et al. The impact of the first 24 h of loop diuretic on kidney function in acute decompensated heart failure. Ir J Med Sci (2020). https://doi.org/10.1007/s11845-020-02426-w
- Acute kidney injury
- Hospital stay
- Loop diuretics